INHSU 2022

19 - 21 October 22

Scottish Event Campus, Glasgow, Scotland + Virtual

Epidemiology and public health in hepatitis C, other infectious diseases, and the broader health of people who use drugs.

 

Poster Presentations

 

19 Oct 20 Oct 21 Oct Posters Pre-conference

 

The poster presentations for INHSU 2022 are grouped into themes. Click on the blue headings/arrows below to view the presentations from each theme. 

To view the abstract, click on the title of the presentation.

 

Themes

Inadequate Needle and Syringe Provision Among People Who Inject Psychoactive Drugs Across England and Wales

Speaker: Lucinda Slater, UK Health Security Agency, United Kingdom


Syringe Re-Use Among People Who Inject Drugs In Rural Appalachia

Speaker: April Young, University of Kentucky, USA


Developing An Intervention Tool Kit For People Experiencing Harm From Cocaine Use

Speaker: Katie Browne, NHS Greater Glasgow And Clyde Alcohol and Drug Recovery Service, UK


Assessing The Feasibility, Acceptability and Accessibility of a Peer-Delivered Intervention to Reduce Harm and Improve The Well-Being of People who Experience Homelessness With Problem Substance Use: The Sharps Study

Speaker: Josh Dumbrell, The Drugs Research Network Scotland, UK


Developing a Community-Based Model of Care For Skin and Soft Tissue Infections and Deep Vein Thromboses in People Who Inject Drugs in Glasgow City Centre

Speaker: Kirsty Paterson, Glasgow Hscp, UK


Drug Consumption Rooms and Peer Involvement: Experiences From Lisbon

Speaker: Adriana Curado, Gat, Portugal


Safe Inhalation Pipe Provision (SIPP): Introducing an Intervention to Reduce Health Harms and Enhance Service Engagement Among People Who Use Crack Cocaine in England

Speaker: Magdalena Harris, London School Of Hygiene & Tropical Medicine, UK


Promoting Safer Supply and Best Practices in Caring for People Who Use Drugs in The Context of Multiple Crisis

Speaker: Marie-ève Goyer, Institut universitaire sur les dépendances, Canada


Service Baskets For Opioid Use Disorder Treatment

Speaker: Marie-ève Goyer, Institut universitaire sur les dépendances, Canada


Post-Overdose Outreach Programs in Massachusetts: Lessons Learned, Impact and Best Practice Guidance

Speaker: Alexander Walley, Boston University School of Medicine, USA


Syringe Services Programs in the Southern and Appalachian United States Ensure Access to Safer Consumption, Overdose Reversal Supplies, and Testing Through Mobile Distribution

Speaker: Bayla Ostrach, Holler Harm Reduction, USA


Do We Have A Choice?: Provider and User Perspectives on Logic of Care for Persons Who Inject Drugs Seeking Harm Reduction Services

Speaker: Carolyn Tauro, University of Oslo, Norway


Too Many Lives Lost: Learning From Global Leaders in Harm Reduction and Treatment

Speaker: Evan Gumas, The Commonwealth Fund, USA


Factors Associated With Skin and Soft Tissue Infections (SSTIS) Among People who Inject Drugs (PWID) in New York City (NYC)

Speaker: Leonardo Dominguez Gomez, Bureau of Alcohol Drug Use Prevention Care and Treatment, New York City Department of Health and Mental Hygiene, USA


The Association Between Problematic Alcohol Consumption, Other Risk Behaviours and Health Outcomes Among People Who Inject Drugs, 2017-2019

Speaker: Claire Edmundson, Civil Service, UK


Alcohol Liaison Nurse – 7 Day Service Providing Care and Treatment to People Presenting to Aberdeen Royal Infirmary With Issues Relating to Problematic Substance Use

Speaker: Carol Mcdougall, Nhs Grampian, UK


Differing Attitudes Towards Harm Reduction Amongst Social Work Professionals in Three Geographical Areas in Sweden

Speaker: Julie Holeksa, Malmö University, Sweden


Factors Associated With Severe Bacterial Infections in People Who Inject Drugs: A Single-Center Observational Study

Speaker: Benjamin Eckhardt, NYU School of Medicine/Bellevue Hospital, USA


Association of Opioid Agonist Treatment With Mortality or Rehospitalization Following Injection Drug Use-Associated Bacterial and Fungal Infections: Linkage Cohort Study

Speaker: Thomas Brothers, Dalhousie University & University College London, Canada


Application of Machine Learning Algorithms For Localized Syringe Services Program Policy Implementation – Florida, 2017

Speaker: Tyler Bartholomew, University Of Miami, USA


Reviewing the Impacts of the Melbourne Supervised Injecting Room

Speaker: Paul Dietze, National Drug Research Institute, Australia


Preferred Gauge of NSP Kit 1 Among People Who Inject Drugs in Nairobi County

Speaker: Sandra Sarune, KRCS, Kenya


Meeting the Moment Project (MTM): Integrating Street Health, Addictions Medicine and Primary Care

Speaker: Sarah Hansen, Nine Circles Community Health Centre, Canada


Prevalence of Mental Disorders Among People With Opioid Use Disorder: A Systematic Review and Meta-Analysis

Speaker: Thomas Santo, National Drug & Alcohol Research Centre, UNSW Sydney, Australia


Unit Costs of Needle and Syringe Program Provision: A Global Systematic Review and Cost Extrapolation

Speaker: Natasha Martin, University Of California San Diego, USA


Smoking Cessation in Substance Use Treatment Services: Staff and Client Perspectives

Speaker: Zoe Swithenbank, Liverpool John Moores University, UK


Long-Term Associations with Childhood Trauma and Mental Disorders Among People With Opioid Dependence

Speaker: Thomas Santo, National Drug & Alcohol Research Centre, UNSW Sydney, Australia


Drug and Hepatitis C Virus Analysis of Residues From Used Syringes Collected at a Needle and Syringe Exchange Programme in Gothenburg, Sweden

Speaker: Simon Larsson, Sahlgrenska University Hospital, Sweden


Chronic Pain: Initial Findings From a Cohort of People Who Inject Drugs in Montreal, Canada

Speaker: Sasha Udhesister, Université De Montréal, Canada

 

Injection Drug Use Patterns and Changes Associated With HCV Treatment

Speaker: Benjamin Eckhardt, NYU School of Medicine/Bellevue Hospital, USA


Association Between History of Incarceration an Prevalence of Drug Use Across 7 Countries in Europe 2014 to 2018

Speaker: Sara Mazzilli, Scuola Normale Superiore, Pisa, Italy


Injecting Drugs On and Off: Factors Associated With Stopping Injection Drug Use Among Young PWID

Speaker: Pedro Mateu-Gelabert, CUNY – School Of Public Health, USA


Prevalence of Injected Drug Use and Access to OAT in People Living in Prison Across 7 Countries in Europe 2014 to 2018

Speaker: Sara Mazzilli, Scuola Normale Superiore, Pisa, Italy


Substance Use Practices Among People who Inject Drugs in Kenya Preparing for Hepatitis C Treatment

Speaker: Lindsey Riback, Albert Einstein College Of Medicine/Montefiore Medical Center, USA


Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids from Chronic Non-Cancer Pain

Speaker: Moussa Konate, Paroles Autour de la Santé, Mali


The Effect of Opioid Analgesics, Benzodiazepines, Gabapentinoids, and Opioid Agonist Treatment On Mortality Risk Among Opioid-Dependent People

Speaker: Chrianna Bharat, NDARC, UNSW Sydney, Australia


Mapping a Global Profile of People who Inject Drugs

Speaker: Louisa Degenhardt, NDARC UNSW, Australia


Risk-Compensation and Loss-To-Follow-Up Among PWID in an HCV Vaccine Trial

Speaker: Nikhet Chowdhury, University Of New Mexico, USA


Adjusting the HCV Comprehension in Colombia: Vulnerable Contexts and the Need to go Beyond Injected Drug Users

Speaker: Levinson Niño, Lanpud, Colombia

A New Model of Care For HCV Elimination in PWUD in The Balearic Islands, Spain

Speaker: Andrea Mochales, ISGlobal, Spain


Bristol and Severn ODN Hepatitis C Outreach: a Flexible Model of Care for Screening

Speaker: Ann Archer, University Hospitals Bristol and Weston, UK


Bridging The Digital Divide & Enhancing Linkage to Hepatitis C Care After Prison Release: The Test Link Call Project

Speaker: Sofia Bartlett, BC Centre for Disease Control, Clinical Prevention Services, Canada


Achieving Micro-Elimination of Hepatitis C in West Kent Change, Grow, Live, the first large, multi-site drug treatment service to do so in England, UK.

Speaker: Jo Brown, Cgl West Kent, UK


The Hep C Drug Treatment Providers Forum HCV Testing Weeks

Speaker: Rebecca John, Turning Point, UK


Use of Modern Screening and Contact Methods in Oat Clinics to Increase HCV Screening and Linkage to Care

Speaker: Kate Johnston, Canadian Addiction Treatment Centres, Canada


Pan-Dorset Hepatitis C Mental Health Engagement Pilot

Speaker: Louise Hansford, Inclusion, UK


Simplified Hepatitis C Testing and Linkage to Care in Addiction Recovery and County Correctional Facilities Model of Care

Speaker: Kathi Scholz, Central Outreach Wellness Center, USA


Peers Power: Increasing the Uptake of HCV Testing and Treatment Amongst People Who Inject Drugs

Speaker: Faizah Hamid, Reachout Centre Trust, Kenya


Effectiveness of Safe Harm Reduction Spaces For Young Persons Who Use Drugs Living With HIV and Viral Hepatitis Co-Infection in Lagos, Nigeria (Aged 15 Yrs – 29 Yrs)

Speaker: James Eghaghe, Equal Health And Rights Access Advocacy Initiative Ehraai, Nigeria


Access Barriers to Diagnosis and Treatment of Hepatitis C For PWID in Pereira (Colombia): The Role of Community Based Organizations

Speaker: Hugo Castro, Ong Temeride, Colombia


More Than Tested, Cured: A Holistic Model of HCV Care Implemented at Syringe Services Programs

Speaker: Mojgan Zare, Atlanta Harm Reduction Coalition, Inc, USA


Belfast Inclusion Health Service – Enhancing Health and Hepatitis Care for People Experiencing Homelessness

Speaker: Bronagh McBrien, Public Health Agency, UK


Keep Your Foot On The Pedal! Kombi Clinic Leads Re-Elimination at Lotus Glen Correctional Centre

Speaker: Mim O’Flynn, Kombi Clinic Ltd, Australia


HIV and HCV Care Continuum Through Testing in the Etet Oeiras/Cascais

Speaker: Ana Marques, Ser+, Portuguese Association For Aids Challenge And Prevention, Portugal


From HCV Diagnosis to Treatment Initiation in Drug Users: Results From a Mobile Outreach Program in Lisbon

Speaker: Claudia Pereira, Ares Do Pinhal, Portugal


Optimising the Opportunity of HCV Testing and Treatment Within a Large Substance Misuse Service

Speaker: Carrie Richardson, The Hepatitis C Trust, UK


The Community Pop-Up Clinic (CPC): a Unique Strategy to Achieve HCV Elimination in The Inner City

Speaker: Brian Conway, Vancouver Infectious Diseases Centre, Canada


A Peer Led Partnership Achieves Whole SMS Service HCV Testing and Treatment

Speaker: Carrie Richardson, The Hepatitis C Trust, UK


Optimizing Clinical Care in The Inner-City Population: Innovative Community HCV-Based Clinic

Speaker: Brian Conway, Vancouver Infectious Diseases Centre, Canada


Hepatitis C Inreach: Opportunistic Inpatient Hepatitis C Identification and Treatment

Speaker: Kim Macbeth, NHS Lothian, UK


“Time To Give It Away” – Peer Led, Same Day Treatment for Hepatitis C: A Pilot Study

Speaker: Julian Surey, Find&Treat, UCLH NHS Trust, UK


A Partnership Approach to Enabling Access to Hepatitis C Treatment Without Visiting The Hospital in a Remote Setting

Speaker: Anngie Everitt, Menzies School Of Health Research, Australia


A Definite Pathway was Successful for HCV Elimination in Caserta Prisons

Speaker: Vincenzo Messina, Uoc Malattie Infettive A.O. S. Anna E S. Sebastiano Caserta, Italy


Outcomes of a Pharmacist-led Care Delivery Model for Patients on Methadone Maintenance Therapy With Chronic Hepatitis C

Speaker: Sara DiTursi, Catholic Health System, USA


Low-Barrier Treatment of Chronic HCV Via Telehealth at a Rural Syringe Exchange Program

Speaker: Sara DeJesus, Berkshire Harm Reduction, USA


Leveraging The Emergency Department as a Public Health Safety Net For Hepatitis C and HIV Services

Speaker: Barbra Cave, University Of Louisville, USA


Detecting and Treating Hepatitis C (HCV) in Addiction Centres in Our Community

Speaker: Sonia Blanco-Sampascual, Hospital universitario Basurto, Spain


Making Hepatitis C Treatment More Accessible: A Test and Treat Mobile Unit in Catalonia

Speaker: Xavier Majó, Programe On Prevention, Care And Control Of Viral Hepatitis (Public Health Agency Of Catalonia), Spain


Adapt The System, Not The Person: Improving the HCV Care Pathways Between the Drug Care Centres and Their Referral Hospitals in Catalonia

Speaker: Xavier Majó, Programe On Prevention, Care And Control Of Viral Hepatitis (Public Health Agency Of Catalonia), Spain


Peers and Medical Staff Testing for Hepatitis C, The Best Match to Reach Drug Users and Make Them Hepatitis Free

Speaker: Juliette Pont, SOS Hépatites Bourgogne Franche-Comté, France


Meeting Clients Wherever They Are At: A Responsive Model of HEP C Care in Toronto, Canada

Speaker: Kate Mason, Toronto Community Hep C Program, Canada


Nurse Practitioner-Led Mobile Health Units Working towards Elimination of Hepatitis C Virus in Rural and Urban South Carolina – A Call to Action

Speaker: Ashley Coleman, Prisma Health, USA


The Importance of a Person-Centred Approach in Achieving Hepatitis C Elimination; Learnings From a Nurse-Led Outreach Hepatitis C Model of Care.

Speaker: Joshua Dawe, Burnet Institute, Australia


A Community-Based Trial of Hepatitis C Treatment at Point of Diagnosis for Marginalized Populations: Preliminary Results From the No One Waits (NOW) Study

Speaker: Meghan Morris, University Of California, San Francisco, USA


A New York City Health Department Collaboration to Improve Hepatitis C Screening and Navigation Services to Underserved Populations

Speaker: Jackilyn Rivera, New York City Dept. Of Health And Mental Hygiene, USA


The HCV Free Hospital, a Simplified Procedure for HCV Screening

Speaker: Vincenzo Messina, Uoc Malattie Infettive A.O. S. Anna E S. Sebastiano Caserta, Italy


Supporting The Development of Effective Monitoring and Evaluation Frameworks in Community Organisation Settings; Learnings From an Australian Hepatitis C Elimination Program

Speaker: Joshua Dawe, Burnet Institute, Australia

Hepatitis C Virus Prevalence From 2010-2015 Among People Experiencing Unstable Housing in a Population – Based Data Linkage Study

Speaker: Sofia Bartlett, BC Centre for Disease Control, Clinical Prevention Services, Canada


Hepatitis C Care Cascade in British Columbia Provincial Correctional Centres Prior to Launch of a Continuous Quality Improvement Project

Speaker: Sofia Bartlett, BC Centre for Disease Control, Clinical Prevention Services, Canada


HCV Prevalence and Risk Behaviours Among People Who Inject Drugs Attending Needle and Syringe Programmes in Lisbon, Portugal

Speaker: Adriana Curado, Gat, Portugal


Prevalence of HCV Infection in Vulnerable Populations: DETECT-C Program a Real Contribution to Hepatitis C Elimination in These Groups in Spain

Speaker: Marinela Mendez, Gilead Science Spain, Spain


One Year of the Drug Consumption Room (DCR) in the City of Lisbon: Preliminary Results of HCV Positive Drug Users and Policy Implications

Speaker: Claudia Pereira, Ares Do Pinhal, Portugal


Hepatitis C Virus Among Patients Visiting a Sexually Transmitted Infections Clinic

Speaker: Michaela Maynard, Brown University, USA


Hepatitis C Virus Prevalence and Outcomes Among Pregnant Women Who Inject Drugs

Speaker: Anthony Martinez, University At Buffalo, USA


Trends in Hepatitis C Prevalence in San Francisco: Progress Toward Elimination

Speaker: Shelley Facente, Facente Consulting, USA


Assessing The Extent of Hepatitis C (HCV) Infection Among Men who Inject Anabolic Androgenic Steroids in The UK: An Urgent Need to Address Uncertainty in Key Parameters to Better Understand the Impact on HCV Elimination.

Speaker: Vivian Hope, PHI, LJMU, UK


Hepatitis C Treatment Among Men Leaving Prison Who Have Histories of Injecting Drug Use in Victoria, Australia

Speaker: Ashleigh Stewart, Burnet Institute, Australia


Hepatitis C Infection Among People Who Use Drugs: A Retrospective Cohort Study Using Administrative Health Records

Speaker: Luca Ceccarelli, University of Pisa, Italy


An Outbreak of Hepatitis C and HIV in Northern Ireland in People who Inject Drugs

Speaker: Sarah Arnold, Public Health Agency, UK


The Road Towards Elimination of Hepatitis C in Oslo: Cross-Sectional Prevalence Studies in 2018 and 2021

Speaker: Eirik Opheim, Agency For Social And Welfare Services, City Of Oslo, Norway, Norway


Modelling of Hepatitis C Elimination in Wales. Is Wales On Track?

Speaker: Brendan Healy, Public Health Wales, UK


HCV Exposure, Chronic Infection and Phylogenetic Linkages in a Community Sample of Young Opioid Users in New York City: Opportunity for HCV Elimination

Speaker: Pedro Mateu-Gelabert, CUNY – School Of Public Health, USA


HCV Genotypes Among Injecting Drug Users Enrolled in Harm Reduction Programs in Tunisia

Speaker: Amin Ghrabi, Florida State University, USA


Evaluating The Population Impact of Hepatitis C Direct Acting Antiviral Treatment as Prevention For People Who Inject Drugs (Epitope) – A Natural Experiment

Speaker: Matt Hickman, Professor in Public Health and Epidemiology, UK


Hepatitis C Treatment Initiation Among People Who Inject Drugs in Australia: Time-to-Event Analysis of a Longitudinal Cohort

Speaker: Phyo Aung, Burnet Institute, Australia 


Increased Uptake of HCV Treatment Associated With Scale-Up of Direct-Acting Antivirals in Community Settings: A National Record-Linkage Study

Speaker: Shanley Smith, Glasgow Caledonian University / Public Health Scotland, UK


Provincial Variability in HCV Testing, Care, and Treatment Across Canada

Speaker: MIa Biondi, York University, Canada


HCV Treatment Among Fentanyl Users: Towards Universal Access to Antiviral Therapy

Speaker: Brian Conway, Vancouver Infectious Diseases Centre, Canada


Identifying Potential Modes of Transmission of Hepatitis C in People Who Inject Drugs Versus the General Population in Punjab, India

Speaker: Roli Tandon, Clinton Health Access Initiative, India


Increasing Linkage to HCV Care Following Trauma-Informed Rehabilitation: An Education and Quality Improvement Project Among Women

Speaker: Agustina Crespi, Viral Hepatitis Care Network, Canada


Awareness of HCV Infection Status Among People Who Inject Drugs in a Setting of Universal Direct-Acting Antiviral Therapy: The Ethos Engage Study

Speaker: Heather Valerio, The Kirby Institute, Australia


Estimating the HCV Treatment Reach in People Who Inject Drugs (PWID) Needed to Meet 2030 WHO Elimination Targets

Speaker: Shiyin Jiao, AbbVie, USA


Micro Elimination of Hepatitis C in Active Drug Users Population Admited for Detoxication in a Unit for Drug Users

Speaker: Davide Cruz, Regional Health Administration Of The Centre (ars Centro, Ip) – Detoxification Unit Of Coimbra (udc), Portugal


Epidemiology of Hepatitis B and Hepatitis C Viruses Among Pregnant Women at Queen Elizabeth Central Hospital (QECH), Malawi

Speaker: Isaac Shawa, University Of Malawi, Malawi


Hepatitis C Elimination Program in Penitentiary Establishments in Central Greece

Speaker: Ioannis Xynotroulas, General Hospital Of Lamia, Greece


Does Combined Needle and Syringe Program and Opioid Agonist Therapy Reduce HIV and Hepatitis C Virus Acquisition Among People Who Inject Drugs in Different Settings?

Speaker: Daniela Van Santen, GGD Amsterdam, Netherlands


Genomic Diversity of HCV Among Intravenous Drug Users in The District of Darjiling, ‘The Queen of Hills’, India

Speaker: Supradip Dutta, National Institute of Cholera and Enteric Diseases, India


Individual and Structural Factors Associated With Recent Hepatitis C Testing in People Who Inject Drugs: Gender-Based Analyses of The Cosinus Cohort

Speaker: Ilhame Anwar, Sesstim Inserm, France


Disparities in Hepatitis C Treatment Uptake Among U.S. Medicaid Enrollees in 2018: Analysis of National Administrative Data

Speaker: Shashi Kapadia, Weill Cornell Medicine, USA


The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition Among People Who Inject Drugs – Findings From a National Survey in England, Wales, and Northern Ireland

Speaker: Peter Vickerman, University Of Bristol, UK


Patient Reported Outcomes of Recovery and Quality of Life Post Hepatitis C Treatment

Speaker: Gabriele Vojt, Glasgow Caledonian University, UK


Ongoing Transmission of HCV Infection in Community Recruited People Who Inject Drugs in Athens, Greece (2018-2020)

Speaker: Sotirios Roussos, National and Kapodistrian University of Athens, Greece


Prevalence of Hepatitis Among Opioid Drug Users Receiving Methadone-Assisted Therapy in Southern Highlands Zone (SHL), Tanzania

Speaker: Adela Peter Luswetula, Hjf Medical Research International, Inc Tanzania, Tanzania


Late Presentation of Chronic Hepatitis C in a Swiss Cohort of People on Opioid Agonist Therapy

Speaker: Alberto Moriggia, Ingrado Servizi per le Dipendenze, Lugano, Epatocentro Ticino SA, Lugano, Switzerland


When Health Department Data Don’t Cut it: Strategies to Track an Epidemic

Speaker: Shelley Facente, Facente Consulting, USA


Genomic Variation of HCV Among Idu Subpopulation in The North-Eastern State of Manipur, India

Speaker: Raina Das, ICMR-NICED, India


Mental Disorders and Hepatitis C Prevalence in People on Opioid Agoniste Therapy Followed at The Sammsu Cohort, Switzerland.

Speaker: Erika Castro, Private Practice – HepC Virtual Clinic, Switzerland


The Relationship Between Opioid Agonist Therapy and Hepatitis C Virus Seroprevalence Among People who Inject Drugs in Southern Appalachian Ohio in 2019

Speaker: Daniel Brook, Ohio State University, USA


High Burden of Blood-Borne Viral Infections (HCV, HIV, HBV) and Sexually Transmitted Infections Among People Experiencing Homelessness – First Results From a Pilot Study in Berlin, Germany

Speaker: Christoph Weber, Checkpoint Bln, Germany


Prevalence of Hepatitis B and C, HIV, and Syphilis Among People Who Inject Drugs in Germany – Results of a Pilot Study For a Periodical National Monitoring System

Speaker: Amrei Krings, Robert Koch-institute, Germany

National Direct Acting Antiviral Utilization For Retreatment of Hepatitis C Virus Due to Reinfection or Virological Failure in Australia

Speaker: Joanne Carson, The Kirby Institute, UNSW Sydney, Australia


Reinfection Rate (RR) in People Who Inject Drugs (PWIDs) After Successful HCV Treatment. Data From an Expertized Hepatology Clinic in Northern Greece (Thessaloniki)

Speaker: Effrosyni Tsirogianni, Fourth Department of Internal Medicine, Hippokration General Hospital, Thessaloniki, Greece


Low Hepatitis C Virus Reinfection in People Who Inject Drugs Treated with Direct Acting Antivirals in Kenya

Speaker: Abbe Muller, Boston University Medical Center, USA


Correlates of HCV Reinfection Among Active Drug Users

Speaker: Brian Conway, Vancouver Infectious Diseases Centre, Canada


Reinfections After Hepatitis C Treatment at a Swedish Needle Exchange Program – Follow-Up On The Actionne Study

Speaker: Marianne Alanko Blomé, Department Of Infectious Diseases, Skåne University Hospital, Malmö, Sweden


HCV Reinfection Rate in Drug Users Who Received DAA Through Decentralized HCV Care Provided in Two Harm Reduction Services In Milan, Italy

Speaker: Sara Mazzilli, Scuola Normale Superiore, Pisa, Italy


Exploring the Lived Experience of HCV Reinfection

Speaker: Amy McEwan, Glasgow Caledonian University, UK


Re-Infection Rates of Hepatitis C in Individuals who Achieved Sustained Virologic Response After Treatment With Direct Acting Antiviral Therapy

Speaker: Sophie Starke, Dalhousie University, Canada

Effect of Social Distancing Measures During the COVID-19 Pandemic on People Who Inject Drugs in Thessaloniki, Greece

Speaker: Effrosyni Tsirogianni, Fourth Department of Internal Medicine, Hippokration General Hospital, Thessaloniki, Greece


Perceptions of and Willingness to Receive COVID-19 Vaccination Among Unvaccinated People Who Use Drugs: New York City, Spring 2021

Speaker: Ashly Jordan, New York City Department Of Health And Mental Hygiene Bureau Of Alcohol And Drug Use Prevention, Use And Treatment, USA


Coping With COVID in Corrections: A Qualitative Study Among the Recently Incarcerated on Pursing Substance Use Disorder Treatment During the Pandemic

Speaker: Lindsey Riback, Albert Einstein College Of Medicine/Montefiore Medical Center, USA


Effect on HCV Treatment Among People Who Inject Drugs During the COVID-19 Pandemic. Data From a Expertized Hepatology Clinic in Northern Greece (Thessaloniki)

Speaker: Effrosyni Tsirogianni, Fourth Department of Internal Medicine, Hippokration General Hospital, Thessaloniki, Greece


Impact of COVID-19 on Substance Use Disorder Treatment Services and Centers; Qualitative Findings From Healthcare Providers in Kenya

Speaker: Abbe Muller, Boston University Medical Center, USA


Factors Associated With Changes in Illicit Opioid Use During the COVID-19 Pandemic Among Incarcerated People Who Use Drugs in Quebec, Canada

Speaker: Nadine Kronfli, Mcgill University, Canada


Addressing HCV, HIV and Syphilis Rates Among Indigenous Populations During COVID-19 Through Community Partnerships

Speaker: Pam Ford, Omega Nurses – Specialty Health Clinic, Canada


Engaging The Disengaged: HCV Self Testing and Linkage to Care for Drug Treatment Service Users During COVID

Speaker: Louise Hansford, Inclusion, UK


Utilization of HCV Outreach Coordinator and Virtual HCV Care by Physician in an Opioid Substitution Clinic and Overdose Prevention Site to Enhance HCV Testing and Linkage to Care in Priority Populations During COVID Pandemic

Speaker: Elisa Venier, AMS/CATC Toronto, ON, Canada


Combined COVID-19 Vaccination and Hepatitis C Virus and HIV Screening Intervention For High-Risk Populations at a Mobile Testing Unit in Madrid, Spain

Speaker: Andrea Mochales, ISGlobal, Spain


COVID-19 Pandemic as a Barrier For Hepatitis C (HCV) Elimination For People Who Use Drugs (PWUD) in Greece

Speaker: Pinelopi Antonakaki, GI-Liver Unit, 2nd Dpt of Internal Medicine, National and Kapodistrian University of Athens,Hippocratio General Hospital, Greece 


Combined COVID-19 Vaccination and Hepatitis C Virus Screening Intervention For High-Risk Populations at a Centre For Addiction Services in Barcelona, Spain

Speaker: Andrea Mochales, ISGlobal, Spain


Innovations for Continuum of Care for People who Inject Drugs During COVID-19 Lock Down

Speaker: Taib Abdulrahman Basheeib, Reachout Centre Trust, Kenya


Implementing Blood Borne Virus (BBV) Self-Testing by Dry Blood Spot Test During the COVID-19 Pandemic in Scotland

Speaker: Caitlin Park, NHS Grampian, UK


Responding to a BBV Outbreak in the Midst of a Global Pandemic

Speaker: Bronagh McBrien, Public Health Agency, UK


COVID-19 Vaccination at a Swedish Needle Exchange Program – A Means of Fighting The Pandemic

Speaker: Eva-lena Öfverström, Department Of Infectious Diseases, University Hospital Skåne, Malmö, Sweden


Hepatitis C Treatment Among People Prescribed Methadone Maintenance at a U.S. Opioid Treatment Program During COVID-19 via Telehealth and Simplified Care Pathway

Speaker: Lynn Taylor, CODAC, USA


Filling The Gap- DBST at Home as a Mitigation for Reduced Face to Face in Alcohol and Drug Recovery Services Contact During COVID

Speaker: Julie Craik, NHS Greater Glasgow and Clyde, UK


Successful Interventions for HCV in The Inner City in COVID World

Speaker: Brian Conway, Vancouver Infectious Diseases Centre, Canada


Evidence of Limited Access to Harm Reduction Services in England, Wales and Northern Ireland in 2020 as a Result of COVID-19 Restrictions

Speaker: Sara Croxford, UK Health Security Agency, UK


Vaccination for SARS-CoV-2 Among Those in Prison Care in Scotland According to Recent Opioid Agonist Therapy History

Speaker: Maxim Wilkinson, Public Health Scotland, UK


Time-Series Analysis of Presentations to Four Syringe Dispensing Machines and a Needle and Syringe Program During COVID-19 Lockdowns in Melbourne, Australia

Speaker: Daniel O’Keefe, Burnet Institute, Australia


Low Prevalence of SARS-CoV-2 Infections and Antibodies Among Clients and Staff Members of Homeless Services in Amsterdam Following The Second Wave of Infections in The Netherlands: Did The Dutch Policy Work?

Speaker: Ellen Generaal, Public Health Service Of Amsterdam, Netherlands


Changes in Substance Use and Risk Behaviours for Hepatitis C Infection Among People Experiencing Homelessness Who Inject Drugs in Northern Ireland During the COVID-19 Pandemic

Speaker: Christopher Nugent, Public Health Agency, Northern Ireland, UK


South Australian Response to Facilitate Isolation Requirements in Aboriginal Homeless Substance Dependent People

Speaker: Bronwyn Gordon, Drug and Alcohol Services South Australia, Australia

 

Call Back: Retrieval of Hepatitis C Diagnosed Patients Who Were Lost to Follow Up. A Study From The C-Free-South Project.

Speaker: Sandra Dröse, Department of Clinical research, Faculty of Health Sciences, University of Southern Denmark, Denmark


Use of a Web Based Dashboard to Identify and Engage With People With Hepatitis C Admitted to Hospital

Speaker: Tom Prior, NHS Greater Glasgow & Clyde, UK


Peer Delivered Hepatitis C Testing in a Community Pharmacy – Meeting the Needs of People Who Inject Drugs

Speaker: Danny Morris, The Hepatitis C Trust, UK


Peer-Led Community Based Integrated Infectious Disease Testing and Linkage to Care in Inclusion Health Populations in London, UK

Speaker: Julian Surey, Find&Treat, UCLH NHS Trust, UK


A Mixed Methods Evaluation of an Innovative Peer+Clinician Outreach HCV Model of Care for Unstably Housed Populations in London, UK, Using the Integrated HCV Candidacy Framework

Speaker: Binta Sultan, Ucl, UK


Using Telephone-Based Patient Navigation Services to Access Hepatitis C Care in New York City With a Public Health Approach

Speaker: Liz Tang, New York City Department Of Health And Mental Hygiene, USA


Drop-In Group Medical Appointments (DIGMAs) Can Improve Patient Engagement in Hepatitis C Treatment

Speaker: Jaclyn Bandell, Western Carolina University, USA


Self Test, What Works Best?

Speaker: Leon Wylie, NHS Lanarkshire, UK


A Novel Testing Modality to Address Barriers to Hepatitis C Testing and Treatment Among Aboriginal and Torres Strait Islander People in New South Wales, Australia: The NSW DBS Pilot Study

Speaker: Anna Conway, Kirby Institute, UNSW, Australia


Integrating Hepatitis C Testing and Treatment Into Multiple Community Healthcare Settings for Those Who Inject Drugs: Facilitators and Barriers

Speaker: Gabriele Vojt, Glasgow Caledonian University, UK


Integrating Hepatitis C Testing and Treatment Into Community Healthcare Settings for Those Who Inject Drugs: Formulating Recommendations

Speaker: Gabriele Vojt, Glasgow Caledonian University, UK


Hepatitis C Virus Testing Uptake Among Hospitalized People Who Inject Drugs: Opportunities to Enhance the HCV Care Continuum

Speaker: Maja Skaland, Norwegian University of Science and Technology, Norway


VEND-C. Evaluating Distribution of Rapid HCV-Antibody Self-Testing Kits via Needle/Syringe Vending Machines: A Protocol Paper

Speaker: Daniel O’Keefe, Burnet Institute, Australia


Using Social Media to Improve Follow-Up and Routine Checks on Newly Diagnosed Young People Living With HIV and Their Adherence to Antiretroviral Therapy in Nigeria

Speaker: Kayode Owoso, 360 Health Systems Diagnostics And Correction (360 HSDC), Nigeria


A Feasibility Study to Increase Chronic Hepatitis C Virus RNA Testing and Linkage to Care Among Clients Attending Homeless Services in Amsterdam, The Netherlands

Speaker: Ellen Generaal, Public Health Service Of Amsterdam, Netherlands


Supporting People Living With HIV to be Cured of Hepatitis C Through Telephone Patient Navigation Services From the New York City Health Department

Speaker: Liz Tang, New York City Department Of Health And Mental Hygiene, USA


Rapid Screening for Blood Borne Viruses Through a Hostel Outreach Programme

Speaker: Bronagh McBrien, Public Health Agency, UK


Cost and Cost-Effectiveness of Hepatitis C Virus Self-Testing in Four Settings

Speaker: Josephine Walker, University Of Bristol, UK


The Role of Point-Of-Care Hepatitis C RNA Testing at Prison Intake For Reducing Barriers to The Hepatitis C Care Cascade

Speaker: Lise Lafferty, UNSW Sydney, Australia


The Drug User in Health Care System: A Training Proposal to Improve Access and Adherence to Care (Linkage to Care)

Speaker: Marcija (Marzia) Borojevic, University of Applied Sciences and Arts of Southern Switzerland Department of Business Economics, Health and Social Care, Switzerland


‘We All Lost Our Steam” – Barriers to Pharmacy-Based Identification and Treatment of Hepatitis C in Victoria, British Columbia

Speaker: Marion Selfridge, Cool Aid Community Health Centre, Canada


Reaching Hard to Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C in High-Income Settings

Speaker: Nicolas Nagot, University of Montpellier, France


Engaging People Who Use Drugs in Tayside Into Care to Decrease Risk of Drug-Related Mortality and Improve Health Outcomes; The ‘Cocoon’ Service Evaluation Project

Speaker: Christian Sharkeys, NHS Tayside, UK


Hepatitis C Treatment Uptake Following Dried Blood Spot Testing For Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot

Speaker: Anna Conway, Kirby Institute, UNSW, Australia


Need For Decentralization and Task-Shifting of Hepatitis C (HCV) Services With a Non-Judgemental Approach for People who Inject Drugs: Results From a Global Values and Preferences Survey

Speaker: Jessica Hicks, World Hepatitis Alliance, UK


A Phone-Based Integrated Intervention for Smoking Cessation Among Smokers Living With Hepatitis C: A Pilot Study

Speaker: Ashley Coleman, Prisma Health, USA


Evaluation of the Impact of HIV Diagnosis on the Hepatitis C Virus Care Cascade and Risk Behaviours Among Persons Receiving Medication Treatment for Opioid Use Disorder

Speaker: Sandra Springer, Yale School Of Medicine, USA


Hepatitis C in People Who Use Drugs: Timeline From Screening to Cure

Speaker: Alexandra Aguiar, Ser+, Portuguese Association For Aids Challenge And Prevention, Portugal


Community Screening in Key Populations: An Integrated Intervention in Two Fast-Track Cities With Significant HIV and Hepatitis C Prevalence

Speaker: Ana Marques, Ser+, Portuguese Association For Aids Challenge And Prevention, Portugal

Hepatitis Delta Virus: A Silent Threat to People Who Inject Drugs

Speaker: Beatrice Zovich, Hepatitis B Foundation, USA


Opportunities to Prevent Hepatitis B Infection Among People Who Use or Inject Drugs

Speaker: Ryan Clary, Hep B United, USA


Unsafe Sexual Practice Prior to Incarceration, a High-Risk Factor of HBV and HIV Infection Among Prisoners In Blantyre, Malawi

Speaker: Isaac Shawa, University Of Malawi, Malawi


Epidemiology of HIV Infection Among People who Inject Drugs in England, Wales and Northern Ireland: Nearly 40 Years On

Speaker: Sara Croxford, UK Health Security Agency, UK


Hepatitis B and C Viral Co-Infections Among HIV-1 Infected Individuals in South Kerala, India

Speaker: Sabin Katpattil, Kerala University Of Health Sciences, India


Ethical Considerations and Responsibilities in the Planning and Implementation of a Study on Infectious Diseases Among People Experiencing Homelessness in Berlin, Germany

Speaker: Navina Sarma, Robert Koch Institute, Germany


“Antihbc(+) Only” as a Marker of Hepatitis B Virus Infection in Drug Users Under Substitution Treatment in Greece

Speaker: Olga Anagnostou, Greek Organization Against Drugs (okana), Greece


Knowledge and Attitude Regarding HBV Infection and Vaccine Among Hospital Patients

Speaker: Asmin Sha, Educare Institute of Health Sciences, India


Screening for Infectious Diseases in At-Risk Populations: Preliminary Data From an Emergency Shelter in Lisbon for Homeless People With Addictions

Speaker: Claudia Pereira, Ares Do Pinhal, Portugal


Contact Tracing to Curbing HIV Transmission by Assessing Sexual Partners, Spouses, and Children of Newly Diagnosed Patients in Nigeria.

Speaker: Kayode Owoso, 360 Health Systems Diagnostics And Correction (360 HSDC), Nigeria

 

Take-Home Naloxone and risk management among people who survived an opioid overdose; a qualitative study informed by drug, set and setting

Speaker: Elin Holmén, Stockholm Centre For Dependency Disorders/Karolinska Institute, Sweden


Psychosocial Predictors of Drug Overdose Among People Who Inject Drugs

Speaker: Oluwaseun Falade-Nwulia, Johns Hopkins University School Of Medicine, USA


Increased Access to Naloxone Among People Who Inject Drugs or Received Opioid Agonist Treatment, Including Those Who Have Experienced Recent Non-Fatal Opioid-Related Overdose in Australia

Speaker: M-J Stowe, Kirby Institute, University Of New South Wales, Australia


The ‘In The Moment Pilot’. Evaluating Methods of In-Situ Data Collection During Episodes of Injecting Drug Use to Improve Opioid Overdose Response: A Protocol Paper

Speaker: Daniel O’Keefe, Burnet Institute, Australia


Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids from Chronic Non-Cancer Pain

Speaker: Fiona Mercer, University Of Stirling, UK


Regional Broad Scale Implementation of Take Home Naloxon in Sweden, 42 Months Follow Up – Small Group Manages Large Proportion of Opioid Overdoses

Speaker: Pernilla Isendahl, Department of Infectious Diseases, University Hospital Skåne, Malmö, Sweden


Innovations in Overdose Prevention: Using the Telephone to Save Lives

Speaker: Amanda Davila, Never Use Alone, USA


Establishing, Embedding, and Supporting Peer Naloxone Supply Across Scotland – A Scottish Drug Deaths Taskforce (DDTF) Funded Project

Speaker: Wez Steele, Scottish Drugs Forum, UK


A Mixed Methods Evaluation of Peer-to-Peer Naloxone Training and Supply in Glasgow, Scotland

Speaker: Mathew Smith, Glasgow Caledonian University, UK


Personal Experience and Awareness of Opioid Overdose Occurrence Among Peers and Willingness to Administer Naloxone in South Africa: Findings From a Three‑City Pilot Survey of Homeless People Who Use Drugs

Speaker: Michael Wilson, Advance Access & Delivery SA, South Africa


Co-Produced Intervention(s) Development for Reducing Drug-Related Deaths in Scotland: A Systems Approach

Speaker: Kathryn Skivington, University of Glasgow, UK


I’ve Changed My Attitude. I’m Not So Against It. Facilitators of Acceptance by Institutional Staff of Canada’s First Prison Overdose Prevention Site

Speaker: Lynne Leonard, University of Ottawa, Canada


Monitoring for Fentanyl and Novel Psychoactive Substances Within Supervised Injecting Facilities: Testing Three Different Approaches in Australia

Speaker: Suzanne Nielsen, Monash Addiction Research Centre, Monash University, Australia


Drug Checking in Australia: Desired Service Design Features Among a Sample of People Who Use Heroin

Speaker: Rachel Sutherland, National Drug and Alcohol Research Centre, Australia


A Realist Synthesis of How Drug Checking Services are Designed and Implemented for People Who Use Drugs.

Speaker: Danilo Falzon, University of Stirling, UK


The HOPE App

Speaker: Eve MacLeod, NHS Highland, UK


Co-Morbidity, Social Experiences, and Service Engagement Among 4,451 Drug-Related Deaths in Scotland 2009-2016: A Network Analysis of 230 Complex Health and Social Conditions

Speaker: Rosie Seaman, University of Glasgow, UK


Emergency Department Visits Due to a Suspected Overdose Following Distribution of Income Assistance Payments in British Columbia, Canada

Speaker: Laurence Campeau, Public Health Agency Of Canada, Canada


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Metzineres. Environments of Shelter for Women Who Use Drugs Surviving Violence

Speaker: Aura Roig Forteza, Metzineres, Spain


“We Come to You”: Co-Locating Counselling With Kirketon Road Centre (KRC) South – A Primary Needle and Syringe Program (NSP) in Sydney’s Southern Region

Speaker: Julie Dubuc, Kirketon Road Centre, Australia


The Harm Reduction Model as a Tool to Enhance Health Care for People who use Drugs (PUD): The Experience of an Outreach Team Working With People who Experience Homelessness (PWEH)

Speaker: Teresa Castro, Ser+, Portuguese Association For Aids Challenge And Prevention, Portugal


Why Case Management is Not Sufficient Anymore… We Need Care Management

Speaker: Tessa Windelinckx, Vzw Free Clinic, Belgium


Improving Access to Addiction Medical Services for Homeless Indigenous Peoples in Montreal: An Integrated Care Model Across a Community-Based Managed Alcohol Program and Hospital-Based Addiction Services

Speaker: Stephanie Marsan, Centre Hospitalier De L’université De Montréal, Canada


Leveraging Public-Private-Community Partnership to Reduce Health Disparities Among People Who Use Drugs

Speaker: Amy Jessop, HepTREC at Prevention Point Philadelphia, USA


Indigenous Peer Mentorship Model of Care

Speaker: Cara Spence, University of Saskatchewan, Canada


Impact of State HIV and Hepatitis C (HCV) Screening Policies on HIV/HCV Testing Provision at Substance Use Disorder (SUD) Treatment Programs in The United States

Speaker: Czarina Behrends, Weill Cornell Medical College, USA


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Development of a Measurement Instrument to Assess The Stigma Affecting People Who Use Drugs in The Western Cape

Speaker: Chanceline Kwakep Semegni, University Of Western Cape, South Africa


Worth The Cure: The Role of Community Engagement and Community-Led Reporting in National Hepatitis Efforts

Speaker: Sara Helena Pereira e Silva Gaspar, Treatment Action Group, Brazil